Neurosurgery for brain tumors: Update on recent technical advances

Current Neurology and Neuroscience Reports

Volumn 11, Issue 3, 2011, Pages 313-319

  Sherman, Jonathan H ^a   Hoes, Kathryn ^b   Marcus, Joshua ^c   Komotar, Ricardo J ^a   Brennan, Cameron W ^a,c   Gutin, Philip H ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

5 Aminolevulinic acid; Diffusion tensor imaging; Functional MRI; Intraoperative; Laser interstitial thermal therapy; MRI

Indexed keywords

AMINOLEVULINIC ACID;

BRAIN MAPPING; BRAIN TUMOR; CANCER SURGERY; COST UTILITY ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION TENSOR IMAGING; FLUORESCENCE IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLIOMA; HEALTH CARE COST; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; LASER THERMOTHERAPY; NEUROIMAGING; NEURONAVIGATION; NEUROSURGERY; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; REVIEW; THERAPY EFFECT; TREATMENT PLANNING; TUMOR LOCALIZATION; DIFFUSION WEIGHTED IMAGING; LASER; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATIENT MONITORING;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LASERS; MAGNETIC RESONANCE IMAGING; MONITORING, INTRAOPERATIVE; NEUROSURGICAL PROCEDURES; PREOPERATIVE CARE;

EID: 79961165506     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-011-0188-9     Document Type: Review

References (51)

1. Barnholtz-Sloan JS, Sloan AE, Davis FG, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22:2865-72. (Pubitemid 41079905)
2. Gu J, Liu Y, Kyritsis AP, Bondy ML. Molecular epidemiology of primary brain tumors. Neurotherapeutics. 2009;6:427-35.
3. Larjavaara S, Mantyla R, Salminen T, et al. Incidence of gliomas by anatomic location. Neuro Oncol. 2007;9:319-25. (Pubitemid 47169665)
4. Legler JM, Ries LA, Smith MA, et al. Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst. 1999;91:1382-90. (Pubitemid 29399996)
5. Smith MA, Freidlin B, Ries LA, Simon R. Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst. 1998;90:1269-77. (Pubitemid 28433471)
6. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278-99.
7. Tsitlakidis A, Foroglou N, Venetis CA, et al. Biopsy versus resection in the management of malignant gliomas: a systematic review and meta-analysis. J Neurosurg. 2010;112:1020-32.
8. Duffau H. Surgery of low-grade gliomas: towards a 'functional neurooncology'. Curr Opin Oncol. 2009;21:543-9.
9. Sanai N, Berger MS. Operative techniques for gliomas and the value of extent of resection. Neurotherapeutics. 2009;6:478-86.
10. Kalkanis SN, Kondziolka D, Gaspar LE, et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 96:33-43.
11. Kinoshita M, Goto T, Okita Y, et al. Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema. J Neurooncol. 2010;96:409-15.
12. Awasthi R, Verma SK, Haris M, et al. Comparative evaluation of dynamic contrast-enhanced perfusion with diffusion tensor imaging metrics in assessment of corticospinal tract infiltration in malignant glioma. J Comput Assist Tomogr. 2010;34:82-8.
13. Bello L, Castellano A, Fava E, et al. Intraoperative use of diffusion tensor imaging fiber tractography and subcortical mapping for resection of gliomas: technical considerations. Neurosurg Focus. 2010;28:E6.
14. Deng Z, Yan Y, Zhong D, et al. Quantitative analysis of glioma cell invasion by diffusion tensor imaging. J Clin Neurosci. 2010.
15. Leclercq D, Duffau H, Delmaire C, et al. Comparison of diffusion tensor imaging tractography of language tracts and intraoperative subcortical stimulations. J Neurosurg. 2010;112:503-11.
16. Jakab A, Molnar P, Emri M, Berenyi E. Glioma grade assessment by using histogram analysis of diffusion tensor imaging-derived maps. Neuroradiology. 2010.
17. Ferda J, Kastner J, Mukensnabl P, et al. Diffusion tensor magnetic resonance imaging of glial brain tumors. Eur J Radiol. 2010;74:428-36.
18. Xu JL, Li YL, Lian JM, et al. Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging. Neuroradiology. 2010.
19. Wang S, Kim S, Chawla S, et al. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage. 2009;44:653-60.
20. Logothetis NK. The underpinnings of the BOLD functional magnetic resonance imaging signal. J Neurosci. 2003;23:3963-71. (Pubitemid 36958412)
21. Ogawa S, Lee TM. Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med. 1990;16:9-18. (Pubitemid 20353794)
22. Zhang D, Johnston JM, Fox MD, et al. Preoperative sensorimotor mapping in brain tumor patients using spontaneous fluctuations in neuronal activity imaged with functional magnetic resonance imaging: initial experience. Neurosurgery. 2009;65:226-36.
23. Jiang Z, Krainik A, David O, et al. Impaired fMRI activation in patients with primary brain tumors. Neuroimage. 2010;52:538-48.
24. Kleiser R, Staempfli P, Valavanis A, et al. Impact of fMRI-guided advanced DTI fiber tracking techniques on their clinical applications in patients with brain tumors. Neuroradiology. 2010;52:37-46.
25. Li SW, Wang JF, Jiang T, et al. Preoperative 3 T high field blood oxygen level dependent functional magnetic resonance imaging for glioma involving sensory cortical areas. Chin Med J (Engl). 2010;123:1006-10.
26. Pantelis E, Papadakis N, Verigos K, et al. Integration of functional MRI and white matter tractography in stereotactic radiosurgeryclinical practice. Int J Radiat Oncol Biol Phys. 2010;78:257-67.
27. Talacchi A, Turazzi S, Locatelli F, et al. Surgical treatment of high-grade gliomas in motor areas. The impact of different supportive technologies: a 171-patient series. J Neurooncol. 2010.
28. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190-8. (Pubitemid 32799739)
29. Hatiboglu MA, Weinberg JS, Suki D, et al. Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis. Neurosurgery. 2009;64:1073-81. discussion 1081.
30. Maesawa S, Fujii M, Nakahara N, et al. Clinical indications for highfield 1.5 T intraoperative magnetic resonance imaging and neuronavigation for neurosurgical procedures. Review of initial 100 cases. Neurol Med Chir (Tokyo). 2009;49:340-9. discussion 349-350.
31. Senft C, Franz K, Ulrich CT, et al. Low field intraoperative MRIguided surgery of gliomas: a single center experience. Clin Neurol Neurosurg. 2010;112:237-43.
32. Senft C, Seifert V, Hermann E, et al. Usefulness of intraoperative ultra low-field magnetic resonance imaging in glioma surgery. Neurosurgery. 2008;63:257-66. discussion 266-257.
33. Ulmer S, Hartwigsen G, Riedel C, et al. Intraoperative dynamic susceptibility contrast MRI (iDSC-MRI) is as reliable as preoperatively acquired perfusion mapping. Neuroimage. 2010;49:2158-62.
34. Ramina R, Coelho Neto M, Giacomelli A, et al. Optimizing costs of intraoperative magnetic resonance imaging. A series of 29 glioma cases. Acta Neurochir (Wien). 2010;152:27-33.
35. Yrjana SK, Katisko JP, Ojala RO, et al. Versatile intraoperative MRI in neurosurgery and radiology. Acta Neurochir (Wien). 2002;144:271-8. discussion 278. (Pubitemid 34299245)
36. Jankovski A, Francotte F, Vaz G, et al. Intraoperative magnetic resonance imaging at 3-T using a dual independent operating room-magnetic resonance imaging suite: development, feasibility, safety, and preliminary experience. Neurosurgery 2008;63:412-24; discussion 424-416.
37. Stummer W, Stepp H, Moller G, et al. Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien). 1998;140:995-1000. (Pubitemid 28508688)
38. Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 1998;42:518-25. discussion 525-516.
39. Blake E, Curnow A. The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells. Photochem Photobiol. 2010;86:1154-60.
40. Valdes PA, SamkoeK, O'Hara JA, et al. Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model. Photochem Photobiol. 2010;86:471-5.
41. Haj-Hosseini N, Richter J, Andersson-Engels S, Wardell K. Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid. Lasers Surg Med. 2010;42:9-14.
42. Nabavi A, Thurm H, Zountsas B, et al. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery. 2009;65:1070-6. discussion 1076-1077.
43. Widhalm G, Wolfsberger S, Minchev G, et al. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer. 2010;116:1545-52.
44. Stummer W, Beck T, Beyer W, et al. Long-sustaining response in a patient with non-resectable, distant recurrence of glioblastoma multiforme treated by interstitial photodynamic therapy using 5-ALA: case report. J Neurooncol. 2008;87:103-9.
45. Stummer W, Tonn JC, Mehdorn HM, et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. J Neurosurg. 2010.
46. Floeth FW, Sabel M, Ewelt C, et al. Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging. 2010.
47. Carpentier A, McNichols RJ, Stafford RJ, et al. Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors. Neurosurgery. 2008;63:ONS21-8. discussion ONS28-29.
48. Leonardi MA, Lumenta CB. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence. Minim Invasive Neurosurg. 2002;45:201-7. (Pubitemid 36098187)
49. Schwarzmaier HJ, Eickmeyer F, von Tempelhoff W, et al. MRguided laser-induced interstitial thermotherapy of recurrent glioblastoma multiforme: preliminary results in 16 patients. Eur J Radiol. 2006;59:208-15. (Pubitemid 44093175)
50. Maroon JC, Onik G, Quigley MR, et al. Cryosurgery re-visited for the removal and destruction of brain, spinal and orbital tumours. Neurol Res. 1992;14:294-302.
51. Anzai Y, Lufkin R, DeSalles A, et al. Preliminary experience with MR-guided thermal ablation of brain tumors. AJNR Am J Neuroradiol. 1995;16:39-48. discussion 49-52.